Univerza na Primorskem Fakulteta za matematiko, naravoslovje in informacijske tehnologije
Več informacij o projektu / More info about the project
Vsebina projekta / Project content
The Slovenian Artificial Intelligence Factory (SLAIF) is a flagship initiative co-funded by EuroHPC and the EC, as well as Slovenia. It is designed to encourage innovation in AI, speed up its use in industry and make Europe more self-sufficient in the digital sector by creating an ecosystem centred on users. Slovenia has a long history of excellence in AI and high-performance computing, which SLAIF will build upon to create an inclusive and sustainable AI ecosystem by using a dedicated AI-optimised HPC facility, a cloud-HPC hybrid infrastructure, and a unified national access point for AI services, tools, and training.
SLAIF will unify Slovenia’s AI ecosystem by connecting academic, industrial, and public actors through shared infrastructure and coordinated services. It will lower entry barriers for SMEs and public institutions through simplified access, tailored support, and lowcode tools. It will enhance the exploitation of national data assets by establishing secure, FAIR-aligned data spaces and semantic catalogues, while ensuring trustworthy and transparent AI systems through integrated explainability, auditing, and compliance mechanisms. Finally, it will strengthen national AI and HPC skills through targeted training, onboarding, and upskilling through hands-on programmes, as well as sector-specific capacity building engaging end-users from the public sector, industry and SMEs.
SLAIF’s vertical services target four domains: green transition, health and biotechnology, digital society, and AI for science. These reflect the diversity and structure of Slovenia’s economy—largely SME-driven, regionally distributed, and technologically varied—and ensure relevance across public and private sectors. Use cases will demonstrate impact in areas such as precision agriculture, medical diagnostics, smart energy systems, and scientific discovery, and will be co-developed with research institutes, hospitals, SMEs, and government bodies.
